Notice Pursuant to the National Cooperative Research and Production Act of 1993-Medical CBRN Defense Consortium (Formerly National Chemical Biological Defense Consortium), 53162-53163 [2016-19035]
Download as PDF
<![CDATA[
53162
Federal Register / Vol. 81, No. 155 / Thursday, August 11, 2016 / Notices
Register pursuant to Section 6(b) of the
Act on June 9, 2016 (81 FR 37215).
Register pursuant to Section 6(b) of the
Act on May 18, 2016 (81 FR 31259).
Patricia A. Brink,
Director of Civil Enforcement, Antitrust
Division.
Patricia A. Brink,
Director of Civil Enforcement, Antitrust
Division.
[FR Doc. 2016–19038 Filed 8–10–16; 8:45 am]
[FR Doc. 2016–19042 Filed 8–10–16; 8:45 am]
BILLING CODE P
BILLING CODE P
DEPARTMENT OF JUSTICE
Antitrust Division
sradovich on DSK3GMQ082PROD with NOTICES
Notice Pursuant to the National
Cooperative Research and Production
Act of 1993—Heterogeneous System
Architecture Foundation
Notice is hereby given that, on July 7,
2016, pursuant to Section 6(a) of the
National Cooperative Research and
Production Act of 1993, 15 U.S.C. 4301
et seq. (‘‘the Act’’), Heterogeneous
System Architecture Foundation (‘‘HSA
Foundation’’) has filed written
notifications simultaneously with the
Attorney General and the Federal Trade
Commission disclosing changes in its
membership. The notifications were
filed for the purpose of extending the
Act’s provisions limiting the recovery of
antitrust plaintiffs to actual damages
under specified circumstances.
Specifically, Friedrich-AlexanderUniversity Erlangen-Nurnberg (FAU),
Erlangen, GERMANY, has been added
as a party to this venture.
Also, Sonics, Inc., Milpitas, CA;
Tensilica, Inc., Santa Clara, CA;
STMicroelectronics International,
Amsterdam, THE NETHERLANDS;
Analog Devices, Inc., Norwood, MA;
Industrial Technology Research Institute
of Taiwan, Hsinchu, TAIWAN; VIA
Technologies, Inc., New Taipei City,
TAIWAN; System Software Lab
National Tsing Hua University,
Hsinchu, TAIWAN; and Tsinghua
University, Beijing, PEOPLE’S
REPUBLIC OF CHINA, have withdrawn
as parties to this venture. No other
changes have been made in either the
membership or planned activity of the
group research project. Membership in
this group research project remains
open, and HSA Foundation intends to
file additional written notifications
disclosing all changes in membership.
On August 31, 2012, HSA Foundation
filed its original notification pursuant to
Section 6(a) of the Act. The Department
of Justice published a notice in the
Federal Register pursuant to Section
6(b) of the Act on October 11, 2012 (77
FR 61786).
The last notification was filed with
the Department on April 12, 2016. A
notice was published in the Federal
17:44 Aug 10, 2016
Antitrust Division
Notice Pursuant to the National
Cooperative Research and Production
Act of 1993—Medical CBRN Defense
Consortium (Formerly National
Chemical Biological Defense
Consortium)
DEPARTMENT OF JUSTICE
Antitrust Division
VerDate Sep<11>2014
DEPARTMENT OF JUSTICE
Jkt 238001
Notice Pursuant to the National
Cooperative Research and Production
Act of 1993—R Consortium, Inc.
Notice is hereby given that, on July
19, 2016, pursuant to Section 6(a) of the
National Cooperative Research and
Production Act of 1993, 15 U.S.C. 4301
et seq. (‘‘the Act’’), R Consortium, Inc.
(‘‘R Consortium’’) has filed written
notifications simultaneously with the
Attorney General and the Federal Trade
Commission disclosing changes in its
membership. The notifications were
filed for the purpose of extending the
Act’s provisions limiting the recovery of
antitrust plaintiffs to actual damages
under specified circumstances.
Specifically, IBM Corporation, Armonk,
NY, has been added as a party to this
venture.
No other changes have been made in
either the membership or planned
activity of the group research project.
Membership in this group research
project remains open, and R Consortium
intends to file additional written
notifications disclosing all changes in
membership.
On September 15, 2015, R Consortium
filed its original notification pursuant to
Section 6(a) of the Act. The Department
of Justice published a notice in the
Federal Register pursuant to Section
6(b) of the Act on October 2, 2015 (80
FR 59815).
The last notification was filed with
the Department on May 23, 2016. A
notice was published in the Federal
Register pursuant to Section 6(b) of the
Act on June 21, 2016 (81 FR 40350).
Patricia A. Brink,
Director of Civil Enforcement, Antitrust
Division.
[FR Doc. 2016–19043 Filed 8–10–16; 8:45 am]
BILLING CODE P
PO 00000
Frm 00045
Fmt 4703
Sfmt 4703
Notice is hereby given that, on June
23, 2016, pursuant to Section 6(a) of the
National Cooperative Research and
Production Act of 1993, 15 U.S.C. 4301
et seq. (‘‘the Act’’), National Chemical
Biological Defense Consortium
(‘‘NCBDC’’) has filed written
notifications simultaneously with the
Attorney General and the Federal Trade
Commission disclosing changes in its
membership. The notifications were
filed for the purpose of extending the
Act’s provisions limiting the recovery of
antitrust plaintiffs to actual damages
under specified circumstances. National
Chemical & Biological Defense
Consortium (‘‘NCBDC’’) has changed its
name to Medical CBRN Defense
Consortium (‘‘MCDC’’). Specifically,
AdjuvanceTechnologies, Inc., New
York, NY; AEQUOR, Inc., Oceanside,
CA; AktiVax, Inc., Boulder, CO; Alchem
Laboratories Corp., Alachua, FL;
Artificial Cell Technologies, Inc., New
Haven, CT; Bach Pharma, Inc., North
Andover, MA; Battelle Memorial
Institute, Columbus, OH; Bryllan LLC,
Brighton, MI; Creare LLC, Hanover, NH;
CUBRC, Inc., Buffalo, NY; Data Sciences
International, Inc., St. Paul, MN; First
Line Technology, LLC, Chantilly, VA;
Ginkgo Bioworks, Boston, MA; Harris
Corporation, Herndon, VA; IIT Research
Institute, Chicago, IL; Integrated
Biotherapeutics, Inc., Gaithersburg, MD;
InvivoSciences, Inc., Madison, WI; Joint
Research and Development, Inc.,
Stafford, VA; Mapp BioPharmaceuticals,
San Diego, CA; MaxCyte, Incorporated,
Gaithersburg, MD; MRIGlobal, Kansas
City, MO; Nanotherapeutics, Inc.,
Alachua, FL; Philips Healthcare,
Andover, MA; Profectus BioSciences,
Inc., Baltimore, MD; ProModel
Corporation, Allentown, PA;
QuickSilver Analytics, Inc., Belcamp,
MD; SciTech Services, Inc., Havre de
Grace, MD; SENTEL Corporation,
Alexandria, VA; Shield Analysis
Technology, LLC, Manassas, VA;
Southwest Research Institute, San
Antonio, TX; SRI International, Menlo
Park, CA; Tech62, Fairfax, VA; Triton
Systems, Inc., Chelmsford, MA;
University of Pittsburgh, Pittsburgh, PA;
University of Tennessee, Knoxville,
Knoxville, TN; and Verndari Inc., Napa,
E:\FR\FM\11AUN1.SGM
11AUN1
Federal Register / Vol. 81, No. 155 / Thursday, August 11, 2016 / Notices
CA, have been added as parties to this
venture.
No other changes have been made in
either the membership or planned
activity of the group research project.
Membership in this group research
project remains open, and MCDC
intends to file additional written
notifications disclosing all changes in
membership.
On November 13, 2015, NCBDC filed
its original notification pursuant to
Section 6(a) of the Act. The Department
of Justice published a notice in the
Federal Register pursuant to Section
6(b) of the Act on January 6, 2016 (81
FR 513).
notification pursuant to Section 6(a) of
the Act. The Department of Justice
published a notice in the Federal
Register pursuant to Section 6(b) of the
Act on November 14, 2014 (79 FR
68301).
The last notification was filed with
the Department on May 2, 2016. A
notice was published in the Federal
Register pursuant to Section 6(b) of the
Act on May 24, 2016 (81 FR 32776).
Patricia A. Brink,
Director of Civil Enforcement, Antitrust
Division.
[FR Doc. 2016–19039 Filed 8–10–16; 8:45 am]
BILLING CODE P
Patricia A. Brink,
Director of Civil Enforcement, Antitrust
Division.
DEPARTMENT OF JUSTICE
[FR Doc. 2016–19035 Filed 8–10–16; 8:45 am]
Antitrust Division
BILLING CODE 4410–11–P
Antitrust Division
sradovich on DSK3GMQ082PROD with NOTICES
Notice Pursuant to the National
Cooperative Research and Production
Act of 1993—Open Platform for NFV
Project, Inc.
Notice is hereby given that, on July
20, 2016, pursuant to Section 6(a) of the
National Cooperative Research and
Production Act of 1993, 15 U.S.C. 4301
et seq. (‘‘the Act’’), Open Platform for
NFV Project, Inc. (‘‘Open Platform for
NFV Project’’) has filed written
notifications simultaneously with the
Attorney General and the Federal Trade
Commission disclosing changes in its
membership. The notifications were
filed for the purpose of extending the
Act’s provisions limiting the recovery of
antitrust plaintiffs to actual damages
under specified circumstances.
Specifically, Beijing Internet Institute,
Beijing, PEOPLE’S REPUBLIC OF
CHINA; Lenovo US, Morrisville, NC;
and Qualcomm Technologies Inc., San
Diego, CA, have been added as parties
to this venture.
Also, Ixia, Calabasas, CA, has
withdrawn as a party to this venture.
In addition, Freescale Semiconductor,
Inc., has changed its name to NXP
Semiconductors, Austin, TX.
No other changes have been made in
either the membership or planned
activity of the group research project.
Membership in this group research
project remains open, and Open
Platform for NFV Project intends to file
additional written notifications
disclosing all changes in membership.
On October 17, 2014, Open Platform
for NFV Project filed its original
VerDate Sep<11>2014
17:44 Aug 10, 2016
Jkt 238001
Notice is hereby given that, on July
14, 2016, pursuant to Section 6(a) of the
National Cooperative Research and
Production Act of 1993, 15 U.S.C. 4301
et seq. (‘‘the Act’’), ODPi, Inc. (‘‘ODPi’’)
has filed written notifications
simultaneously with the Attorney
General and the Federal Trade
Commission disclosing changes in its
membership. The notifications were
filed for the purpose of invoking the
Act’s provisions limiting the recovery of
antitrust plaintiffs to actual damages
under specified circumstances.
Specifically, Splunk Inc., San Francisco,
CA; and 4C Decision, Herndon, VA,
have been added as parties to this
venture.
No other changes have been made in
either the membership or planned
activity of the group research project.
Membership in this group research
project remains open, and ODPi intends
to file additional written notifications
disclosing all changes in membership.
On November 23, 2015, ODPi filed its
original notification pursuant to Section
6(a) of the Act. The Department of
Justice published a notice in the Federal
Register pursuant to Section 6(b) of the
Act on December 23, 2015 (80 FR
79930).
The last notification was filed with
the Department on April 29, 2016. A
notice was published in the Federal
Register pursuant to Section 6(h) of the
Act on May 24, 2016 (81 FR 32777).
Patricia A. Brink,
Director of Civil Enforcement, Antitrust
Division.
[FR Doc. 2016–19036 Filed 8–10–16; 8:45 am]
BILLING CODE 4410–11–P
PO 00000
Frm 00046
Fmt 4703
Sfmt 4703
DEPARTMENT OF JUSTICE
[OMB Number 1117–0004]
Agency Information Collection
Activities; Proposed eCollection,
eComments Requested; Extension
Without Change of a Previously
Approved Collection Application for
Permit To Export Controlled
Substances, Application for Permit To
Export Controlled Substances for
Subsequent Reexport—DEA Forms
161, 161R
Drug Enforcement
Administration, Department of Justice
ACTION: 30-day notice.
AGENCY:
The Department of Justice
(DOJ), Drug Enforcement
Administration (DEA), will be
submitting the following information
collection request to the Office of
Management and Budget (OMB) for
review and approval in accordance with
the Paperwork Reduction Act of 1995.
This proposed information collection
was previously published in the Federal
Register at 81 FR 38220, June 13, 2016,
allowing for a 60 day comment period.
DATES: Comments are encouraged and
will be accepted for an additional 30
days until September 12, 2016.
FOR FURTHER INFORMATION CONTACT: If
you have comments on the estimated
public burden or associated response
time, suggestions, or need a copy of the
proposed information collection
instrument with instructions or
additional information, please contact
Michael J. Lewis, Office of Diversion
Control, Drug Enforcement
Administration; Mailing Address: 8701
Morrissette Drive, Springfield, Virginia
22152; Telephone: (202) 598–6812 or
sent to OIRA_submissions@
omb.eop.gov.
SUMMARY:
Notice Pursuant to the National
Cooperative Research and Production
Act of 1993—ODPI, Inc.
DEPARTMENT OF JUSTICE
53163
Written
comments and suggestions from the
public and affected agencies concerning
the proposed collection of information
are encouraged. Your comments should
address one or more of the following
four points:
—Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
—Evaluate the accuracy of the agency’s
estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
—Evaluate whether and if so how the
quality, utility, and clarity of the
SUPPLEMENTARY INFORMATION:
E:\FR\FM\11AUN1.SGM
11AUN1
]]>Agencies
[Federal Register Volume 81, Number 155 (Thursday, August 11, 2016)]
[Notices]
[Pages 53162-53163]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-19035]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Antitrust Division
Notice Pursuant to the National Cooperative Research and
Production Act of 1993--Medical CBRN Defense Consortium (Formerly
National Chemical Biological Defense Consortium)
Notice is hereby given that, on June 23, 2016, pursuant to Section
6(a) of the National Cooperative Research and Production Act of 1993,
15 U.S.C. 4301 et seq. (``the Act''), National Chemical Biological
Defense Consortium (``NCBDC'') has filed written notifications
simultaneously with the Attorney General and the Federal Trade
Commission disclosing changes in its membership. The notifications were
filed for the purpose of extending the Act's provisions limiting the
recovery of antitrust plaintiffs to actual damages under specified
circumstances. National Chemical & Biological Defense Consortium
(``NCBDC'') has changed its name to Medical CBRN Defense Consortium
(``MCDC''). Specifically, AdjuvanceTechnologies, Inc., New York, NY;
AEQUOR, Inc., Oceanside, CA; AktiVax, Inc., Boulder, CO; Alchem
Laboratories Corp., Alachua, FL; Artificial Cell Technologies, Inc.,
New Haven, CT; Bach Pharma, Inc., North Andover, MA; Battelle Memorial
Institute, Columbus, OH; Bryllan LLC, Brighton, MI; Creare LLC,
Hanover, NH; CUBRC, Inc., Buffalo, NY; Data Sciences International,
Inc., St. Paul, MN; First Line Technology, LLC, Chantilly, VA; Ginkgo
Bioworks, Boston, MA; Harris Corporation, Herndon, VA; IIT Research
Institute, Chicago, IL; Integrated Biotherapeutics, Inc., Gaithersburg,
MD; InvivoSciences, Inc., Madison, WI; Joint Research and Development,
Inc., Stafford, VA; Mapp BioPharmaceuticals, San Diego, CA; MaxCyte,
Incorporated, Gaithersburg, MD; MRIGlobal, Kansas City, MO;
Nanotherapeutics, Inc., Alachua, FL; Philips Healthcare, Andover, MA;
Profectus BioSciences, Inc., Baltimore, MD; ProModel Corporation,
Allentown, PA; QuickSilver Analytics, Inc., Belcamp, MD; SciTech
Services, Inc., Havre de Grace, MD; SENTEL Corporation, Alexandria, VA;
Shield Analysis Technology, LLC, Manassas, VA; Southwest Research
Institute, San Antonio, TX; SRI International, Menlo Park, CA; Tech62,
Fairfax, VA; Triton Systems, Inc., Chelmsford, MA; University of
Pittsburgh, Pittsburgh, PA; University of Tennessee, Knoxville,
Knoxville, TN; and Verndari Inc., Napa,
[[Page 53163]]
CA, have been added as parties to this venture.
No other changes have been made in either the membership or planned
activity of the group research project. Membership in this group
research project remains open, and MCDC intends to file additional
written notifications disclosing all changes in membership.
On November 13, 2015, NCBDC filed its original notification
pursuant to Section 6(a) of the Act. The Department of Justice
published a notice in the Federal Register pursuant to Section 6(b) of
the Act on January 6, 2016 (81 FR 513).
Patricia A. Brink,
Director of Civil Enforcement, Antitrust Division.
[FR Doc. 2016-19035 Filed 8-10-16; 8:45 am]
BILLING CODE 4410-11-P
